PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
21 06 2019
Historique:
received: 08 11 2017
revised: 01 02 2019
accepted: 20 05 2019
entrez: 23 6 2019
pubmed: 23 6 2019
medline: 16 5 2020
Statut: ppublish

Résumé

The role of nonclassical monocytes (NCMs) in health and disease is emerging, but their location and function within tissues remain poorly explored. Imaging of NCMs has been limited by the lack of an established single NCM marker. Here, we characterize the immune checkpoint molecule PD-L1 (CD274) as an unequivocal marker for tracking NCMs in circulation and pinpoint their compartmentalized distribution in tissues by two-photon microscopy. Visualization of PD-L1

Identifiants

pubmed: 31227596
pii: 4/36/eaar3054
doi: 10.1126/sciimmunol.aar3054
pii:
doi:

Substances chimiques

Antibodies 0
B7-H1 Antigen 0
Cd274 protein, mouse 0
Immunoglobulin G 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Mariaelvy Bianchini (M)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Johan Duchêne (J)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany. jduchen@med.lmu.de chweber@med.lmu.de.

Donato Santovito (D)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Maximilian J Schloss (MJ)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Maximilien Evrard (M)

Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648 Singapore.
School of Biological Sciences, Nanyang Technological University, 637551 Singapore.

Holger Winkels (H)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Maria Aslani (M)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Sarajo K Mohanta (SK)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Michael Horckmans (M)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Xavier Blanchet (X)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Michael Lacy (M)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Philipp von Hundelshausen (P)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.

Dorothee Atzler (D)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.
Walther Straub Institute of Pharmacology and Toxicology, University of Munich, 80336 Munich, Germany.

Andreas Habenicht (A)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.

Norbert Gerdes (N)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.

Jaroslav Pelisek (J)

Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.

Lai Guan Ng (LG)

Singapore Immunology Network (SIgN), A*STAR (Agency for Science, Technology and Research), Biopolis, 138648 Singapore.
School of Biological Sciences, Nanyang Technological University, 637551 Singapore.

Sabine Steffens (S)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, 80336 Munich, Germany.

Christian Weber (C)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany. jduchen@med.lmu.de chweber@med.lmu.de.
Cardiovascular Research Institute Maastricht, University of Maastricht, 6229 ER, Maastricht, Netherlands.

Remco T A Megens (RTA)

Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität (LMU), 80336 Munich, Germany.
Cardiovascular Research Institute Maastricht, University of Maastricht, 6229 ER, Maastricht, Netherlands.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH